Therefore, Separase represents an ideal therapeutic target to eliminate Separase-overexpressed aneuploid tumors including various breast tumor subtypes, and Sepins offer a promising avenue for breast and other cancer therapeutics. The gene discussed is ESPL1; the disease is cancer.